The START trial, a multicenter phase 3 randomized controlled study, reports that new dosing schedules can be considered after surgery. Medscape Medical News
Ivabradine was no better than placebo in terms of reducing cardiac death and other coronary and heart-failure outcomes in the overall trial population; however, patients with heart rates higher than 70 bpm had reduced hospitalizations for heart failure and MI and reduced revascularizations with ivabradine. Heartwire
Results of a new study show an association between muscle pain reactions to the initiation of statin therapy and a subsequent diagnosis of sporadic ALS. The researchers speculate that statins may unmask incipient ALS. Medscape Medical News
